IP10 (CXCL10) Mouse Monoclonal Antibody [Clone ID: 4D5]
CAT#: SM1323P
IP10 (CXCL10) mouse monoclonal antibody, clone 4D5, Purified
Need it in bulk or conjugated?
Get a free quote
CNY 7304.00
货期*
4周
规格
Product images
Specifications
| Product Data | |
| Clone Name | 4D5 |
| Applications | ELISA, WB |
| Recommend Dilution | ELISA: 1-2 µg/ml. Western Blot. |
| Reactivity | Human |
| Host | Mouse |
| Clonality | Monoclonal |
| Immunogen | Recombinant human IP-10. Spleen cells from immunised Balb/c mice were fused with cells of the mouse P3X63-AgP-653 myeloma cell line. |
| Specificity | This antibody recognises both natural and recombinant IP-10, also known as CXCL10. |
| Isotype | IgG1 |
| Formulation | PBS, pH7.4 containing 0.09% Sodium Azide State: Purified State: Liquid purified IgG |
| Concentration | lot specific |
| Purification | Affinity chromatography on Protein G |
| Conjugation | Unconjugated |
| Storage Condition | Store the antibody undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer. Avoid repeated freezing and thawing. |
| Gene Name | C-X-C motif chemokine ligand 10 |
| Database Link | |
| Background | Interferon-gamma-inducible 10 kD protein (IP-10), is a CXC chemokine with chemoattractant properties for CD4-positive T cells and inhibits early normal and leukemic hemopoietic progenitor proliferation. IP-10 is produced by a wide variety of cell types ranging from neutrophils and monocytes to hepatocytes, endothelial cells and keratinocytes. The cytokine is reported to be involved in a scala of inflammatory pathologies such as HIV encephalitis, cutaneous T cell lymphoma, chronic hepatitis and acute anterior uveitis. Various observations strongly suggest a role for the CXC chemokines IL-8 and IP-10 in the regulation of angiogenic activity in cancer and in idiopathic pulmonary fibrosis. |
| Synonyms | C-X-C motif chemokine 10, Small-inducible cytokine B10, Gamma-IP10, INP10, SCYB10 |
| Reference Data | |
Documents
| Product Manuals |
| FAQs |
| SDS |
Resources
| 抗体相关资料 |
Customer
Reviews
Loading...
